Insights

Oncogenes, previously thought to drive cancer solely through genetic mutations, may actually initiate cancer by epigenetically reprogramming cells. This discovery opens new avenues for cancer treatment and intervention strategies.

Area of Science:

  • Oncology
  • Epigenetics
  • Cancer Biology

Background:

  • The traditional view posits that oncogenes are the primary drivers of cancer, making them key therapeutic targets.
  • This model is supported by the observation that most cancer cells share common oncogenic genetic mutations.

Purpose of the Study:

  • To analyze recent evidence suggesting oncogenes initiate cancer through epigenetic reprogramming.
  • To explore the role of oncogenes in developmental reprogramming of the epigenome.
  • To discuss novel anti-cancer intervention strategies based on this new understanding.

Main Methods:

  • Review and analysis of existing research on oncogene-target cell interactions.
  • Examination of studies linking epigenetic reprogramming to carcinogenesis.
  • Discussion of implications for cancer origin and treatment.

Main Results:

  • Oncogenes can induce cancer development by epigenetically reprogramming target cells.
  • Carcinogenesis may be initiated by epigenetic stem cell reprogramming.
  • This highlights a novel role for oncogenes in cancer's origin.

Conclusions:

  • The understanding of oncogenes' role in cancer is evolving beyond genetic mutations.
  • Epigenetic reprogramming by oncogenes offers new perspectives on cancer development.
  • This paradigm shift may lead to innovative therapeutic approaches.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.3K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
28.6K
Epigenetic Regulation01:46

Epigenetic Regulation

23.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.6K
Inheritance of Chromatin Structures03:17

Inheritance of Chromatin Structures

Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
6.0K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.2K